Shareman your FDA info states 50 + antiviral treatments being tested. How many of those have been fast track approved and how many are in phase 2 with a human safety profile?
I think you will find that almost all of them (bar Merck and Pfizer) are either in pre animal trials or phase 1animal trials . No human safety data . No chance next year of phase 2 or early approval.
FDA will want more options than Pfizer or Merck’s dubious drug. Like most drugs not everyone can take them.
Then there is also the price point. At $500 or $700 / coarse there is miles of room in the market. Pfizer may simply buy us out just to own the market and also have something for HIV and HepC as a bonus. I believe if proved effective in human trials early next year chance of buyout will be high even if low balled for only a few billion.
Lets see if this goes to phase 2 on the accelerated path . Plenty of time for us all to make money.
- Forums
- ASX - By Stock
- BIT
- chart daily
chart daily, page-2242
-
- There are more pages in this discussion • 1,052 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.4¢ |
Change
0.001(3.03%) |
Mkt cap ! $30.67M |
Open | High | Low | Value | Volume |
3.4¢ | 3.4¢ | 3.3¢ | $632 | 18.85K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 287617 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 37989 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 287617 | 0.033 |
3 | 215000 | 0.032 |
2 | 332500 | 0.031 |
8 | 540666 | 0.030 |
1 | 100000 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 10000 | 1 |
0.036 | 65500 | 1 |
0.037 | 537816 | 2 |
0.039 | 490546 | 3 |
0.040 | 113240 | 2 |
Last trade - 13.36pm 19/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |